全文获取类型
收费全文 | 80631篇 |
免费 | 7296篇 |
国内免费 | 4567篇 |
专业分类
耳鼻咽喉 | 112篇 |
儿科学 | 3695篇 |
妇产科学 | 331篇 |
基础医学 | 6300篇 |
口腔科学 | 468篇 |
临床医学 | 8351篇 |
内科学 | 18984篇 |
皮肤病学 | 572篇 |
神经病学 | 1497篇 |
特种医学 | 3662篇 |
外国民族医学 | 6篇 |
外科学 | 25511篇 |
综合类 | 9855篇 |
现状与发展 | 14篇 |
一般理论 | 2篇 |
预防医学 | 2154篇 |
眼科学 | 1246篇 |
药学 | 4223篇 |
21篇 | |
中国医学 | 1420篇 |
肿瘤学 | 4070篇 |
出版年
2024年 | 86篇 |
2023年 | 1099篇 |
2022年 | 1617篇 |
2021年 | 2785篇 |
2020年 | 2751篇 |
2019年 | 2788篇 |
2018年 | 2860篇 |
2017年 | 2641篇 |
2016年 | 2748篇 |
2015年 | 2828篇 |
2014年 | 5077篇 |
2013年 | 5240篇 |
2012年 | 4432篇 |
2011年 | 5031篇 |
2010年 | 4585篇 |
2009年 | 4704篇 |
2008年 | 4796篇 |
2007年 | 4938篇 |
2006年 | 4839篇 |
2005年 | 4149篇 |
2004年 | 3237篇 |
2003年 | 2776篇 |
2002年 | 2320篇 |
2001年 | 2017篇 |
2000年 | 1725篇 |
1999年 | 1362篇 |
1998年 | 1187篇 |
1997年 | 1094篇 |
1996年 | 936篇 |
1995年 | 834篇 |
1994年 | 876篇 |
1993年 | 541篇 |
1992年 | 616篇 |
1991年 | 452篇 |
1990年 | 332篇 |
1989年 | 327篇 |
1988年 | 317篇 |
1987年 | 214篇 |
1986年 | 178篇 |
1985年 | 208篇 |
1984年 | 149篇 |
1983年 | 84篇 |
1982年 | 116篇 |
1981年 | 115篇 |
1980年 | 79篇 |
1979年 | 63篇 |
1978年 | 79篇 |
1977年 | 59篇 |
1976年 | 50篇 |
1974年 | 31篇 |
排序方式: 共有10000条查询结果,搜索用时 462 毫秒
41.
42.
《Arab Journal Of Gastroenterology》2021,22(3):229-235
Background and Study AimsIn developing countries, endemic indications, blood shortages, and the scarcity of liver surgeons and intensive care providers can affect liver resection (LR) outcomes, but these have been rarely addressed in the literature. Therefore, in this study we determined risk factors for major complications after LR in a North African general surgery and teaching department.Patients and MethodsFrom January 2010 to December 2015, 213 consecutive LRs were performed on 203 patients. All patients underwent a postoperative follow-up of >90 days. Postoperative complications were assessed according to the Clavien–Dindo (CD) classification of surgical complications. A score of CD ≥III is considered as major postoperative complications. In this study, we analyzed the variables assumed to affect these complications.ResultsThe overall 90-day complication rate was 35.7% (n = 76), including a CD ≥III of 14% (n = 30) and a mortality rate of 6.1% (n = 14). According to the multivariate analysis, a preoperative performance status (PS) of ≥2 (P = 0.011; odds ratios [OR], 6.8; 95% confidence intervals [CI], 1.55–29.8), an estimated intraoperative blood loss of >500 ml (P = 0.002; OR, 3.71; 95% CI, 1.23–11.20), and bilioenteric anastomosis (P < 0.004; OR, 7.76; 95% CI, 1.5–3.89) were independent risk factors for major complications after LR.ConclusionWe recommend that, in the setting of a non-Eastern/non-Western general surgery and teaching department, patients with a PS of ≥2 should undergo a specific selection and preoperative optimization protocol; intermittent clamping indications should be extended; and special attention should paid to patients undergoing LR associated with biliary reconstruction, such as for perihilar cholangiocarcinoma. 相似文献
43.
ObjectiveThe beneficial effects of carnitine supplementation on nonalcoholic fatty liver disease are unclear. We conducted a systematic review and meta-analysis to evaluate the effects of carnitine supplementation on liver function, lipid profile, body mass index, body weight, and homeostasis model assessment of insulin resistance in patients with nonalcoholic fatty liver disease.MethodsA comprehensive search of PubMed, Web of Science, Scopus, Cochrane Library, and Google Scholar databases were performed. Only randomized placebo-controlled human studies that examined the effects of carnitine supplementation on liver function, lipid profile, body mass index, body weight, and homeostasis model assessment of insulin resistance up to September 2019 were included. Fixed effects or random-effects models were applied to compute the pooled effect size. Heterogeneity assessments were performed using Cochran’s Q test and I-squared statistics. The quality of the studies was assessed using the Jaded scale.ResultsA total of 5 articles were selected, including 334 individuals (167 in control and 167 in intervention groups). The results demonstrated that carnitine supplementation significantly reduced homeostasis model assessment of insulin resistance (HOMA-IR) (WMD: −0.91; 95 % CI: −1.11, −0.72; p < 0.001, I2 = 0.0 %) and the levels of aspartate aminotransferase (AST) (WMD: −16.62; 95 % CI: −28.11, −5.14; IU/l; p = 0.005, I2 = 93.5 %), alanine aminotransferase (ALT) (WMD: -33.39; 95 % CI: −45.13, −21.66; IU/l; p < 0.001, I2 = 93.4 %), and triglycerides (TG) (WMD: −22.13; 95 % CI: −38.91, −5.34; mg/dl; p = 0.01; I2 = 0.0 %). However, the results of the pooled effect size did not show any significant effect of carnitine supplementation on body mass index (BMI) (WMD: 0.07; 95 % CI: −0.15, 0.29; p = 0.55; I2 = 0.0 %), body weight (WMD: −0.28; 95 % CI: −2.23, 1.68; p = 0.78; I2 = 45.7 %), the levels of gamma-glutamyl transferase (γGT) (WMD: −11.31; 95 % CI: −24.35, 1.73; IU/l; p = 0.09, I2 = 61.1 %), cholesterol (WMD: −13.58; 95 % CI: −46.77, 19.60; mg/dl; p = 0.42; I2 = 94.9 %), high-density lipoprotein-cholesterol (HDL-C) (WMD: 1.36; 95 % CI: −0.96, 3.68; mg/dl; p = 0.25; I2 = 64.7 %), and low density lipoprotein-cholesterol (LDL-C) (WMD: −14.85; 95 % CI: −45.43, 15.73; mg/dl; p = 0.34; I2 = 96.4 %).ConclusionsThis analysis shows that carnitine supplementation for patients with nonalcoholic fatty liver disease demonstrates a reduction in AST, ALT, TG levels and HOMA-IR. However, no significant effect of carnitine supplementation was observed on BMI, body weight, the levels of γGT, TC, HDL-cholesterol and LDL-cholesterol. 相似文献
44.
45.
46.
Astrid Ruiz-Marg in Berenice M Rom n-Calleja Paulina Moreno-Guill n Jos A Gonz lez-Regueiro Deyanira K sulas-Delint Alejandro Campos-Murgu a Nayelli C Flores-Garc a Ricardo Ulises Mac as-Rodr guez 《World journal of gastrointestinal oncology》2021,13(10):1440-1452
Hepatocellular carcinoma (HCC) is the most frequent primary liver cancer and presents together with cirrhosis in most cases. In addition to commonly recognized risk factors for HCC development, such as hepatitis B virus/hepatitis C virus infection, age and alcohol/tobacco consumption, there are nutritional risk factors also related to HCC development including high intake of saturated fats derived from red meat, type of cooking (generation of heterocyclic amines) and contamination of foods with aflatoxins. On the contrary, protective nutritional factors include diets rich in fiber, fruits and vegetables, n-3 polyunsaturated fatty acids and coffee. While the patient is being evaluated for staging and treatment of HCC, special attention should be paid to nutritional support, including proper nutritional assessment and therapy by a multidisciplinary team. It must be considered that these patients usually develop HCC on top of long-lasting cirrhosis, and therefore they could present with severe malnutrition. Cirrhosis-related complications should be properly addressed and considered for nutritional care. In addition to traditional methods, functional testing, phase angle and computed tomography scan derived skeletal muscle index-L3 are among the most useful tools for nutritional assessment. Nutritional therapy should be centered on providing enough energy and protein to manage the increased requirements of both cirrhosis and cancer. Supplementation with branched-chain amino acids is also recommended as it improves response to treatment, nutritional status and survival, and finally physical exercise must be encouraged and adapted to individual needs. 相似文献
47.
48.
《中国现代医生》2020,58(34):112-115
目的 探讨地佐辛术后镇痛对高龄患者围术期肝功能的影响。方法 选择2018 年1 月~2020 年6 月吉安市中心人民医院麻醉科收治的ASA 分级Ⅱ~Ⅲ级高龄患者80 例,按照随机数字表法,分为A 组、B 组、C 组、D 组,每组各20 例。分别给予0.4 mg/kg、0.5 mg/kg、0.6 mg/kg、0.7 mg/kg 地佐辛进行术后镇痛,评估术后1、2、6、12、24、48 h 患者的疼痛程度[视觉模拟评分法(VAS)]、术后镇静效果(Ramsay 评分法)及肝功能指标(ALT、AST)水平,评价不同剂量的地佐辛术后镇痛对高龄患者围术期肝功能的影响。结果 C 组术后患者不同时间段VAS 疼痛评分低于A 组、B 组、D 组,差异有统计学意义(P<0.05);四组患者术后1、2、6 h Ramsay 镇静评分比较,差异有统计学意义(P<0.05);但术后12、24、48 h Ramay 镇痛评分比较,差异无统计学意义(P>0.05)。C 组肝功能指标ALT、AST优于A 组、B 组、D 组,差异有统计学意义(P<0.05)。结论 高龄患者术后镇痛应用0.6 mg/kg地佐辛对围术期肝功能的影响最小。 相似文献
49.
50.
Worsening pneumonitis due to a pharmacokinetic drug–drug interaction between everolimus and voriconazole in a renal transplant patient 下载免费PDF全文